Impact of Previous Stroke on Short-Term Myocardial Reinfarction in Patients With Acute ST Segment Elevation
Li Tian1, Yanmin Yang, Jun Zhu
1From the Department of cardiology, The Second Affiliated Hospital of Harbin Medical University, The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education (LT, BY); State Key Laboratory of Cardiovascular Disease, Emergency and Critical Care Centre of Cardiovascular Department, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China (YY, JZ, LL, YL, JL).
Insights
Short-term myocardial reinfarction is common after ST-elevation myocardial infarction (STEMI). Previous stroke significantly increases this risk, while statin use can reduce it, highlighting key factors for STEMI patient care.
Area of Science:
- Cardiology
- Neurology
- Public Health
Background:
- Myocardial reinfarction is a frequent complication following ST-elevation myocardial infarction (STEMI).
- A significant proportion of STEMI patients have a history of previous stroke, a known cardiovascular risk factor.
Purpose of the Study:
- To evaluate risk factors for short-term myocardial reinfarction in STEMI patients.
- To investigate the association between previous stroke and short-term reinfarction rates.
- To assess the impact of statin use on reinfarction risk in STEMI patients.
Main Methods:
- A multicenter study enrolled 6876 STEMI patients in China with chest pain onset within 12 hours.
- Patients underwent 7- and 30-day follow-ups.
- Kaplan-Meier survival analysis and multivariable Cox regression were used to identify independent predictors of 30-day myocardial reinfarction.
Main Results:
- The overall 30-day myocardial reinfarction rate was 2.0%.
- STEMI patients with a history of previous stroke had a significantly higher 30-day reinfarction rate (4.2%) compared to those without (P < 0.001).
- Previous stroke (HR, 3.673) and statin use (HR, 0.230) were identified as independent predictors for 30-day myocardial reinfarction.
Conclusions:
- A substantial number of STEMI patients have a history of stroke, posing a higher risk for short-term reinfarction.
- Previous stroke is a significant independent risk factor for short-term myocardial reinfarction post-STEMI.
- Statin therapy demonstrates a protective effect, reducing the risk of short-term myocardial reinfarction in STEMI patients.
Abstract:
Myocardial reinfarction is frequent after ST-elevation myocardial infarction (STEMI). The incidence of previous stroke in STEMI patients is also high. We aim to evaluate the risk factors for short-term myocardial reinfarction in STEMI patients in a multicenter study.STEMI patients with chest pain onset within 12 hours in 247 hospitals in China were enrolled. Seven and 30-day follow-ups from admission to hospitals were performed. The primary outcome of our study was myocardial reinfarction at 30 days after STEMI. The study population was stratified into 2 groups: STEMI patients with mayocardial reinfarction and without mayocardial reinfarction. Survival curve was constructed using Kaplan-Meier survival methods with log-rank statistics. Multivariable Cox regression model was performed to determine the risk factors for myocardial reinfarction events in STEMI patients.A total of 6876 STEMI patients were enrolled. The proportion of STEMI patients with previous stroke was 9.4%. Rate of 30-day myocardial reinfarction was 2.0% among all STEMI patients. Rate of 30-day myocardial reinfarction was 4.2% in STEMI patients with previous stroke which was statistically higher than that in STEMI patients without previous stroke (P < 0.001). Multivariable Cox regression analysis showed that previous stroke (HR, 3.673; 95% CI, 1.180-11.43) and statin use (HR, 0.230; 95% CI, 0.080-0.664) were independent predictors for 30-day myocardial reinfarction.A large proportion of STEMI patients had previous stroke history. Short-term myocardial reinfarction after STEMI is not infrequent. STEMI patients with previous stroke confronted higher rates of short-term myocardial reinfarction and statin could decline the risk of short-term myocardial reinfarction.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care


